All Stories

  1. Hair cortisol, allostatic load, and depressive symptoms in Australian Aboriginal and Torres Strait Islander people
  2. Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
  3. Social Inequalities and the Road to Allostatic Load: From Vulnerability to Resilience
  4. Stress and allostatic load in Indigenous Australians
  5. Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia
  6. Prolonged Subcutaneous Administration of Oxytocin Accelerates Angiotensin II-Induced Hypertension and Renal Damage in Male Rats
  7. Lifelong, central corticotropin-releasing factor (CRF) overexpression is associated with individual differences in cocaine-induced conditioned place preference
  8. Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents
  9. “More than skin deep”: stress neurobiology and mental health consequences of racial discrimination
  10. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes
  11. Guest editorial
  12. Oxytocin in learning and addiction: From early discoveries to the present
  13. INCREASED PREVALENCE OF DIVERSE N-METHYL-D-ASPARTATE GLUTAMATE RECEPTOR ANTIBODIES IN PATIENTS WITH AN INITIAL DIAGNOSIS OF SCHIZOPHRENIA
  14. Correction: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
  15. Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia
  16. Estudos traducionais de neuropsiquiatria e esquizofrenia: modelos animais genéticos e de neurodesenvolvimento
  17. An exploratory study of cannabis withdrawal among Indigenous Australian prison inmates: study protocol
  18. Molecular Validation of the Acute Phencyclidine Rat Model for Schizophrenia: Identification of Translational Changes in Energy Metabolism and Neurotransmission
  19. Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis
  20. Optogenetics: potentials for addiction research
  21. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity
  22. Influence of transgenic corticotropin-releasing factor (CRF) over-expression on social recognition memory in mice
  23. Oxytocin as a potential mediator and modulator of drug addiction
  24. Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes
  25. Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders
  26. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
  27. Decreased expression of multidrug efflux transporters in the brains of GSK-3β transgenic mice
  28. Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice
  29. Modeling Networks of Glycolysis, Overall Energy Metabolism and Drug Metabolism under a Systems Biology Approach
  30. Functional Abnormalities in the Hippocampus and Impaired Hippocampal-dependent Learning in Mice Lacking the 5HT1A Receptors
  31. Adaptive Changes in Postsynaptic Dopamine Receptors Despite Unaltered Dopamine Dynamics in Mice Lacking Monoamine Oxidase B
  32. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?
  33. OXYTOCIN AND ADDICTION: A REVIEW
  34. Neurobiology of Stress and Cocaine Addiction: Studies on Corticotropin-Releasing Factor in Rats, Monkeys, and Humansa
  35. Neuroendocrine-Related Effects of Long-Term, ‘Binge’ Cocaine Administration: Diminished Individual Differences in Stress-Induced Corticosterone Response
  36. Oxytocin blocks the development of heroin-fentanyl cross-tolerance in mice
  37. Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats
  38. Role of oxytocin in the neuroadaptation to drugs of abuse
  39. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats
  40. Cocaine-induced elevation of plasma corticosterone is mediated by different neurotransmitter systems in rats
  41. Measurement of Cocaine-Induced Stereotyped Behavior in Response to Neuropeptides
  42. Role of Endogenous Corticotropin Releasing Factor in Mediation of Neuroendocrine and Behavioral Responses to Cholecystokinin Octapeptide Sulfate Ester in Rats
  43. Opposite actions of oxytocin and vasopressin in the development of cocaine-induced behavioral sensitization in mice
  44. Oxytocin blocks the development of heroin-enkephalin cross-tolerance in mice
  45. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats
  46. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats
  47. Effects of Cocaine and Pimozide on Plasma and Brain Alpha-Melanocyte-Stimulating Hormone Levels in Rats
  48. The inhibition of oxytocin-induced grooming by a specific receptor antagonist
  49. Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice
  50. Central effects of the potent and highly selective μ opioid antagonist (CTOP) in mice
  51. Chapter 10 Neurohypophyseal hormones and behavior
  52. Development of morphine tolerance under tonic control of brain oxytocin